Success Metrics

Clinical Success Rate
92.9%

Based on 26 completed trials

Completion Rate
93%(26/28)
Active Trials
4(10%)
Results Posted
50%(13 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_3
9
23%
Ph not_applicable
5
13%
Ph phase_1
6
15%
Ph phase_4
8
21%
Ph phase_2
9
23%

Phase Distribution

6

Early Stage

9

Mid Stage

17

Late Stage

Phase Distribution37 total trials
Phase 1Safety & dosage
6(16.2%)
Phase 2Efficacy & side effects
9(24.3%)
Phase 3Large-scale testing
9(24.3%)
Phase 4Post-market surveillance
8(21.6%)
N/ANon-phased studies
5(13.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

26 of 30 finished

Non-Completion Rate

13.3%

4 ended early

Currently Active

4

trials recruiting

Total Trials

39

all time

Status Distribution
Active(4)
Completed(26)
Terminated(4)
Other(5)

Detailed Status

Completed26
unknown5
Recruiting3
Withdrawn2
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
39
Active
4
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (16.2%)
Phase 29 (24.3%)
Phase 39 (24.3%)
Phase 48 (21.6%)
N/A5 (13.5%)

Trials by Status

recruiting38%
unknown513%
active_not_recruiting13%
completed2667%
withdrawn25%
terminated25%

Recent Activity

Clinical Trials (39)

Showing 20 of 39 trialsScroll for more
NCT04851015Phase 3

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

Recruiting
NCT03178149Phase 1

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Recruiting
NCT04502095Phase 4

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Completed
NCT02944825Not Applicable

Antibiotic Prophylaxis With Routine Ureteral Stent Removal

Completed
NCT02096159Not Applicable

Prophylactic Antibiotics or Placebo After Hypospadias Repair

Active Not Recruiting
NCT06499233Phase 4

Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease

Recruiting
NCT02021006Phase 3

Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract

Unknown
NCT00324922Phase 3

Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis

Completed
NCT03228108Phase 4

Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.

Completed
NCT00061945Phase 1

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Completed
NCT04639817

Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study

Completed
NCT00867789Not Applicable

Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department

Terminated
NCT02475876Phase 1

PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children

Completed
NCT00789464Phase 2

Probiotics for Girls With Recurring Urinary Tract Infections

Withdrawn
NCT01595529Phase 2

The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"

Completed
NCT01792804Phase 3

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

Completed
NCT00405704Phase 3

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

Completed
NCT00791505Phase 3

Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation

Completed
NCT01632891Phase 1

Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected

Completed
NCT01659866Phase 4

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
39